pubmed-article:12270582 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:12270582 | lifeskim:mentions | umls-concept:C0282402 | lld:lifeskim |
pubmed-article:12270582 | lifeskim:mentions | umls-concept:C0043210 | lld:lifeskim |
pubmed-article:12270582 | lifeskim:mentions | umls-concept:C0021368 | lld:lifeskim |
pubmed-article:12270582 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
pubmed-article:12270582 | lifeskim:mentions | umls-concept:C0232970 | lld:lifeskim |
pubmed-article:12270582 | lifeskim:mentions | umls-concept:C0445550 | lld:lifeskim |
pubmed-article:12270582 | lifeskim:mentions | umls-concept:C2745888 | lld:lifeskim |
pubmed-article:12270582 | pubmed:issue | 1 | lld:pubmed |
pubmed-article:12270582 | pubmed:dateCreated | 2002-9-24 | lld:pubmed |
pubmed-article:12270582 | pubmed:abstractText | Concentrations of soluble fractions of cell adhaesion molecules [sCAM], C-reactive protein (CRP) and serum amyloid A (SAA) are predictive for future cardiovascular events in postmenopausal women. The effect of hormone replacement therapy (HRT) on these inflammatory markers is not uniform. In the presented study the effect of a low-dose HRT preparation, on sCAM, CRP and SAA in healthy postmenopausal women was evaluated. | lld:pubmed |
pubmed-article:12270582 | pubmed:language | eng | lld:pubmed |
pubmed-article:12270582 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12270582 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:12270582 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12270582 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12270582 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12270582 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12270582 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12270582 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12270582 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12270582 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12270582 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12270582 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12270582 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12270582 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12270582 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:12270582 | pubmed:month | Sep | lld:pubmed |
pubmed-article:12270582 | pubmed:issn | 0378-5122 | lld:pubmed |
pubmed-article:12270582 | pubmed:author | pubmed-author:KyurkchievSta... | lld:pubmed |
pubmed-article:12270582 | pubmed:author | pubmed-author:GoudevAssenA | lld:pubmed |
pubmed-article:12270582 | pubmed:author | pubmed-author:GeorgievDimit... | lld:pubmed |
pubmed-article:12270582 | pubmed:author | pubmed-author:KoychevaNeven... | lld:pubmed |
pubmed-article:12270582 | pubmed:author | pubmed-author:ManasievNicko... | lld:pubmed |
pubmed-article:12270582 | pubmed:copyrightInfo | Copyright 2002 Elsevier Science Ireland Ltd. | lld:pubmed |
pubmed-article:12270582 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:12270582 | pubmed:day | 30 | lld:pubmed |
pubmed-article:12270582 | pubmed:volume | 43 | lld:pubmed |
pubmed-article:12270582 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:12270582 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:12270582 | pubmed:pagination | 49-53 | lld:pubmed |
pubmed-article:12270582 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
pubmed-article:12270582 | pubmed:meshHeading | pubmed-meshheading:12270582... | lld:pubmed |
pubmed-article:12270582 | pubmed:meshHeading | pubmed-meshheading:12270582... | lld:pubmed |
pubmed-article:12270582 | pubmed:meshHeading | pubmed-meshheading:12270582... | lld:pubmed |
pubmed-article:12270582 | pubmed:meshHeading | pubmed-meshheading:12270582... | lld:pubmed |
pubmed-article:12270582 | pubmed:meshHeading | pubmed-meshheading:12270582... | lld:pubmed |
pubmed-article:12270582 | pubmed:meshHeading | pubmed-meshheading:12270582... | lld:pubmed |
pubmed-article:12270582 | pubmed:meshHeading | pubmed-meshheading:12270582... | lld:pubmed |
pubmed-article:12270582 | pubmed:meshHeading | pubmed-meshheading:12270582... | lld:pubmed |
pubmed-article:12270582 | pubmed:meshHeading | pubmed-meshheading:12270582... | lld:pubmed |
pubmed-article:12270582 | pubmed:meshHeading | pubmed-meshheading:12270582... | lld:pubmed |
pubmed-article:12270582 | pubmed:meshHeading | pubmed-meshheading:12270582... | lld:pubmed |
pubmed-article:12270582 | pubmed:meshHeading | pubmed-meshheading:12270582... | lld:pubmed |
pubmed-article:12270582 | pubmed:meshHeading | pubmed-meshheading:12270582... | lld:pubmed |
pubmed-article:12270582 | pubmed:meshHeading | pubmed-meshheading:12270582... | lld:pubmed |
pubmed-article:12270582 | pubmed:meshHeading | pubmed-meshheading:12270582... | lld:pubmed |
pubmed-article:12270582 | pubmed:meshHeading | pubmed-meshheading:12270582... | lld:pubmed |
pubmed-article:12270582 | pubmed:meshHeading | pubmed-meshheading:12270582... | lld:pubmed |
pubmed-article:12270582 | pubmed:year | 2002 | lld:pubmed |
pubmed-article:12270582 | pubmed:articleTitle | Effects of low dose hormone replacement therapy on markers of inflammation in postmenopausal women. | lld:pubmed |
pubmed-article:12270582 | pubmed:affiliation | Department of Internal Medicine 2, Preventive Cardiology Clinic, Medical University Sofia, 1 G Sofiiski St, 1431 Sofia, Bulgaria. goudev@hotmail.com | lld:pubmed |
pubmed-article:12270582 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:12270582 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12270582 | lld:pubmed |